Profile of darunavir in the management of treatment-experienced HIV patients
Cameron Wolfe, Charles HicksDuke University Medical Center, Division of Infectious Diseases, Durham, NC, USAAbstract: Darunavir (formerly TMC114) is a second-generation, sulfonamide-based, peptidomimetic protease inhibitor (PI) with a modified 3-dimensional structure enabling more efficient binding...
Guardado en:
Autores principales: | Cameron Wolfe, Charles Hicks |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2009
|
Materias: | |
Acceso en línea: | https://doaj.org/article/f8f886a94fd04aa68ae968125536033c |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Role of darunavir in the management of HIV infection
por: R Monica Lascar, et al.
Publicado: (2009) -
Profile of maraviroc: a CCR5 antagonist in the management of treatment-experienced HIV patients
por: Thore Lorenzen
Publicado: (2010) -
The role of etravirine in the management of treatment-experienced pediatric patients with HIV
por: Osterholzer D
Publicado: (2013) -
Optimizing management of treatment-naïve and treatment-experienced HIV+ patients: the role of maraviroc
por: Eva Poveda, et al.
Publicado: (2010) -
Profile of once-daily darunavir/cobicistat fixed-dose combination for the treatment of HIV/AIDS
por: Navarro J, et al.
Publicado: (2016)